Michèle Provencher

9PUBLICATIONS
106CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 22, 2026
Carboplatin Plus Mirvetuximab Soravtansine In Platinum-Sensitive Ovarian Cancer: A Phase 2 Nonrandomized Clinical Trial.

|Jan 15, 2025
SMARCA4 regulates the NK-mediated killing of senescent cells.

Virinder Reen, Mariantonietta D'Ambrosio, Pia Pernille Søgaard

|Oct 03, 2024
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.

Jung-Min Lee, Mark F Brady, Austin Miller

|May 01, 2023
Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial.

Oliver Dorigo, Amit M Oza, Tanja Pejovic

|Feb 25, 2023
Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene.

Caitlin T Fierheller, Wejdan M Alenezi, Corinne Serruya

|Jun 23, 2022
A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers.

Anna V Tinker, Alon D Altman, Marcus Q Bernardini

Pageof 2

Frequent Collaborators

3 joint publications

Iain A McNeish

3 joint publications

Anne-Marie Mes-Masson

2 joint publications

Prafull Ghatage

2 joint publications

Rebecca S Kristeleit